Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

709 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Inflammation-related proteins as biomarkers of treatment-related behavioral symptoms: A longitudinal study of breast cancer patients and age-matched controls.
Patel SK, Breen EC, Paz IB, Kruper L, Mortimer J, Wong FL, Bhatia S, Irwin MR, Behrendt CE. Patel SK, et al. Among authors: mortimer j. Brain Behav Immun Health. 2023 Jul 31;32:100670. doi: 10.1016/j.bbih.2023.100670. eCollection 2023 Oct. Brain Behav Immun Health. 2023. PMID: 37637432 Free PMC article.
Predicting All-Cause Mortality in Women With and Without Breast Cancer Using the Schonberg Index: A Women's Health Initiative Study.
Nelson RA, Soto-Perez-de-Celis E, Chlebowski RT, Schonberg M, Mortimer J, Pan K, Hou L, Neuhouser ML, Reding KW, Saquib N, Wactawski-Wende J, Wolfson E, Sedrak MS, Kruper L. Nelson RA, et al. Among authors: mortimer j. J Natl Compr Canc Netw. 2023 Jun;21(6):636-644.e13. doi: 10.6004/jnccn.2023.7015. J Natl Compr Canc Netw. 2023. PMID: 37308127
Pilot study of HER2 targeted 64 Cu-DOTA-tagged PET imaging in gastric cancer patients.
Hernandez MC, Yazaki P, Mortimer JE, Yamauchi D, Poku E, Park J, Frankel P, Kim J, Colcher DM, Wong J, Fong Y, Shively J, Woo Y. Hernandez MC, et al. Among authors: mortimer je. Nucl Med Commun. 2023 Dec 1;44(12):1151-1155. doi: 10.1097/MNM.0000000000001761. Epub 2023 Oct 30. Nucl Med Commun. 2023. PMID: 37901917
A phase I study of Mirvetuximab Soravtansine and gemcitabine in patients with FRα-positive recurrent ovarian, primary peritoneal, fallopian tube, or endometrial cancer, or triple negative breast cancer.
Cristea MC, Stewart D, Synold T, Ruel N, Mortimer J, Wang E, Jung A, Wilczynski S, Konecny GE, Eng M, Kilpatrick L, Han E, Dellinger T, Hakim A, Lee S, Morgan RJ, Wakabayashi MT, Frankel PH. Cristea MC, et al. Among authors: mortimer j. Gynecol Oncol. 2024 Mar;182:124-131. doi: 10.1016/j.ygyno.2023.12.017. Epub 2024 Jan 22. Gynecol Oncol. 2024. PMID: 38262235 Clinical Trial.
709 results